IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma

Name: IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma
License: Public Domain

Baylor Research Institute

ClinicalTrials.gov · Datasets · License: Public Domain

malignant melanoma stage iii, malignant melanoma stage iv

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 363654
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.